435 related articles for article (PubMed ID: 32235291)
1. Histone Deacetylation Inhibitors as Modulators of Regulatory T Cells.
von Knethen A; Heinicke U; Weigert A; Zacharowski K; Brüne B
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235291
[TBL] [Abstract][Full Text] [Related]
2. Trichostatin A promotes the generation and suppressive functions of regulatory T cells.
Doñas C; Fritz M; Manríquez V; Tejón G; Bono MR; Loyola A; Rosemblatt M
Clin Dev Immunol; 2013; 2013():679804. PubMed ID: 23737814
[TBL] [Abstract][Full Text] [Related]
3. Microbiota-derived butyrate limits the autoimmune response by promoting the differentiation of follicular regulatory T cells.
Takahashi D; Hoshina N; Kabumoto Y; Maeda Y; Suzuki A; Tanabe H; Isobe J; Yamada T; Muroi K; Yanagisawa Y; Nakamura A; Fujimura Y; Saeki A; Ueda M; Matsumoto R; Asaoka H; Clarke JM; Harada Y; Umemoto E; Komatsu N; Okada T; Takayanagi H; Takeda K; Tomura M; Hase K
EBioMedicine; 2020 Aug; 58():102913. PubMed ID: 32711255
[TBL] [Abstract][Full Text] [Related]
4. Glucocorticoid hormone differentially modulates the in vitro expansion and cytokine profile of thymic and splenic Treg cells.
Pap R; Ugor E; Litvai T; Prenek L; Najbauer J; Németh P; Berki T
Immunobiology; 2019 Mar; 224(2):285-295. PubMed ID: 30612787
[TBL] [Abstract][Full Text] [Related]
5. Epigenetical Targeting of the FOXP3 Gene by S-Adenosylmethionine Diminishes the Suppressive Capacity of Regulatory T Cells Ex Vivo and Alters the Expression Profiles.
Sahin E; Sahin M
J Immunother; 2019 Jan; 42(1):11-22. PubMed ID: 30407230
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic Variability of CD4+CD25+ Tregs Contributes to the Pathogenesis of Autoimmune Diseases.
Shu Y; Hu Q; Long H; Chang C; Lu Q; Xiao R
Clin Rev Allergy Immunol; 2017 Apr; 52(2):260-272. PubMed ID: 27687891
[TBL] [Abstract][Full Text] [Related]
7. Histone deacetylase 6 and heat shock protein 90 control the functions of Foxp3(+) T-regulatory cells.
de Zoeten EF; Wang L; Butler K; Beier UH; Akimova T; Sai H; Bradner JE; Mazitschek R; Kozikowski AP; Matthias P; Hancock WW
Mol Cell Biol; 2011 May; 31(10):2066-78. PubMed ID: 21444725
[TBL] [Abstract][Full Text] [Related]
8. FOXP3+ regulatory T cell development and function require histone/protein deacetylase 3.
Wang L; Liu Y; Han R; Beier UH; Bhatti TR; Akimova T; Greene MI; Hiebert SW; Hancock WW
J Clin Invest; 2015 Mar; 125(3):1111-23. PubMed ID: 25642770
[TBL] [Abstract][Full Text] [Related]
9. Immunosuppressive therapy influences the accelerated age-dependent T-helper cell differentiation in systemic lupus erythematosus remission patients.
Schaier M; Gottschalk C; Uhlmann L; Speer C; Kälble F; Eckstein V; Müller-Tidow C; Meuer S; Mahnke K; Lorenz HM; Zeier M; Steinborn A
Arthritis Res Ther; 2018 Dec; 20(1):278. PubMed ID: 30563559
[TBL] [Abstract][Full Text] [Related]
10. Histone/protein deacetylase inhibitors increase suppressive functions of human FOXP3+ Tregs.
Akimova T; Ge G; Golovina T; Mikheeva T; Wang L; Riley JL; Hancock WW
Clin Immunol; 2010 Sep; 136(3):348-63. PubMed ID: 20478744
[TBL] [Abstract][Full Text] [Related]
11. Differential effects of 2-deoxy-D-glucose on in vitro expanded human regulatory T cell subsets.
Tanimine N; Germana SK; Fan M; Hippen K; Blazar BR; Markmann JF; Turka LA; Priyadharshini B
PLoS One; 2019; 14(6):e0217761. PubMed ID: 31170216
[TBL] [Abstract][Full Text] [Related]
12. EZH2 deficiency attenuates Treg differentiation in rheumatoid arthritis.
Xiao XY; Li YT; Jiang X; Ji X; Lu X; Yang B; Wu LJ; Wang XH; Guo JB; Zhao LD; Fei YY; Yang HX; Zhang W; Zhang FC; Tang FL; Zhang JM; He W; Chen H; Zhang X
J Autoimmun; 2020 Mar; 108():102404. PubMed ID: 31952907
[TBL] [Abstract][Full Text] [Related]
13. Valproate treatment of human cord blood CD4-positive effector T cells confers on them the molecular profile (microRNA signature and FOXP3 expression) of natural regulatory CD4-positive cells through inhibition of histone deacetylase.
Fayyad-Kazan H; Rouas R; Merimi M; El Zein N; Lewalle P; Jebbawi F; Mourtada M; Badran H; Ezzeddine M; Salaun B; Romero P; Burny A; Martiat P; Badran B
J Biol Chem; 2010 Jul; 285(27):20481-91. PubMed ID: 20427269
[TBL] [Abstract][Full Text] [Related]
14. tTregs, pTregs, and iTregs: similarities and differences.
Shevach EM; Thornton AM
Immunol Rev; 2014 May; 259(1):88-102. PubMed ID: 24712461
[TBL] [Abstract][Full Text] [Related]
15. Histone/protein deacetylase inhibitor therapy for enhancement of Foxp3+ T-regulatory cell function posttransplantation.
Wang L; Beier UH; Akimova T; Dahiya S; Han R; Samanta A; Levine MH; Hancock WW
Am J Transplant; 2018 Jul; 18(7):1596-1603. PubMed ID: 29603600
[TBL] [Abstract][Full Text] [Related]
16. Peripherally induced regulatory T cells contribute to the control of autoimmune diabetes in the NOD mouse model.
Schuster C; Jonas F; Zhao F; Kissler S
Eur J Immunol; 2018 Jul; 48(7):1211-1216. PubMed ID: 29604048
[TBL] [Abstract][Full Text] [Related]
17. Histone deacetylase inhibitors and transplantation.
Tao R; de Zoeten EF; Ozkaynak E; Wang L; Li B; Greene MI; Wells AD; Hancock WW
Curr Opin Immunol; 2007 Oct; 19(5):589-95. PubMed ID: 17719760
[TBL] [Abstract][Full Text] [Related]
18. In Vitro Differentiation of Human CD4+FOXP3+ Induced Regulatory T Cells (iTregs) from Naïve CD4+ T Cells Using a TGF-β-containing Protocol.
Schmidt A; Éliás S; Joshi RN; Tegnér J
J Vis Exp; 2016 Dec; (118):. PubMed ID: 28060341
[TBL] [Abstract][Full Text] [Related]
19. PDCD5 negatively regulates autoimmunity by upregulating FOXP3(+) regulatory T cells and suppressing Th17 and Th1 responses.
Xiao J; Liu C; Li G; Peng S; Hu J; Qu L; Lv P; Zhang Y; Ma D; Chen Y
J Autoimmun; 2013 Dec; 47():34-44. PubMed ID: 24012345
[TBL] [Abstract][Full Text] [Related]
20. Analysis of FOXP3
Schmidt A; Rieger CC; Venigalla RK; Éliás S; Max R; Lorenz HM; Gröne HJ; Krammer PH; Kuhn A
Immunol Res; 2017 Apr; 65(2):551-563. PubMed ID: 28224362
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
